Search in:

Expert Opinion on Drug Metabolism & Toxicology Volume 3, 2007 - Issue 1

Submit an article Journal homepage

114

Views

CrossRef citations to date

Altmetric

Review

Toxicological and clinical computational analysis and the US FDA/CDER

R Daniel Benz ICSAS Database Manager, US Food and Drug Administration, Informatics and Computational Safety Analysis Staff, Office of Pharmaceutical Science, Center for Drug Evaluation and Research, 10903 New Hampshire Ave., Silver Spring, MD 20993, USA. [email protected]

Pages 109-124 | Published online: 01 Feb 2007

Cite this article
https://doi.org/10.1517/17425255.3.1.109

Full Article
Figures & data
References
Citations
Metrics
Reprints & Permissions

Bibliography

JOHNSON MA, MAGGIORA GM: Concepts and Applications of Molecular Similarity. Wiley, New York, USA (1990).
Google Scholar
MATTHEWS EJ, CONTRERA JF: A new highly specific method for predicting the carcinogenic potential of pharmaceuticals in rodents using enhanced MCASE QSAR ES software. Regul. Toxicol. Pharmacol. (1998)28:242-264.
PubMed Web of Science ®Google Scholar
CONTRERA JF, MATTHEWS EJ, BENZ RD: Predicting the carcinogenic potential of pharmaceuticals in rodents using molecular structural similarity and E-state indices. Regul. Toxicol. Pharmacol. (2003)38:243-259.
PubMed Web of Science ®Google Scholar
MATTHEWS EJ, KRUHLAK NL, CIMINO MC, BENZ RD, CONTRERA JF: An analysis of genetic toxicity, reproductive and developmental toxicity, and carcinogenicity data: I. Identification of carcinogens using surrogate endpoints. Regul. Toxicol. Pharmacol. (2006)44:83-96.
PubMed Web of Science ®Google Scholar
CONTRERA JF, MATTHEWS EJ, KRUHLAK NL, BENZ RD: In silico screening of chemicals for bacterial mutagenicity using electrotopological E-state indices and MDL QSAR software. Regul. Toxicol. Pharmacol. (2005)43:313-323.
PubMed Web of Science ®Google Scholar
MATTHEWS EJ, BENZ RD, KRUHLAK NL, CONTRERA JF: Analysis of reproductive and developmental toxicity data: I. Development of weight of evidence QSAR database. Regul. Toxicol. Pharmacol. (2007) (In Press)
Google Scholar
MATTHEWS EJ, KRUHLAK NL, BENZ RD, CONTRERA JF: Assessment of the health effects of chemicals in humans: I. QSAR estimation of the maximum recommended therapeutic dose (MRTD) and no effect level (NOEL) of organic chemicals based on clinical trial data. Curr. Drug Disc. Technol. (2004)1:61-76.
PubMedGoogle Scholar
CONTRERA JF, MATTHEWS EJ, KRUHLAK NL, BENZ RD: Estimating the safe starting dose in Phase I clinical trials and no observed effect level based on QSAR modeling of the human maximum recommended daily dose. Regul. Toxicol. Pharmacol. (2004)40:185-206.
PubMed Web of Science ®Google Scholar
KLOPMAN G: Artificial intelligence approach to structure-activity studies. Computer automated structure evaluation of biological activity of organic molecules. J. Am. Chem. Soc. (1984)106:7315-7320.
Web of Science ®Google Scholar
CONTRERA JF, MACLAUGHLIN P, HALL LH, KIER LB: QSAR modelling of carcinogenic risk using discriminant analysis and topological molecular descriptors. Curr. Drug Discov. Tecnol. (2005)2:55-67.
PubMedGoogle Scholar
COOPER JA, SARACCI R, COLE P: Describing the validity of carcinogen screening tests. Br. J. Cancer (1979)39:87-89.
PubMed Web of Science ®Google Scholar
MATTHEWS EJ, KRUHLAK NL, CIMINO MC, BENZ RD, CONTRERA JF: Analysis of genetic toxicity, reproductive and developmental toxicity, and carcinogenicity data: II. Identification of genotoxicants, reprotoxicants, and carcinogens using in silico methods. Regul. Toxicol. Pharmacol. (2006)44:97-110.
PubMed Web of Science ®Google Scholar
MATTHEWS EJ, KRUHLAK NL, BENZ RD, IVANOV J, KLOPMAN G, CONTRERA JF: A comprehensive model for reproductive and developmental toxicity hazard identification: II. Construction of QSAR models to predict activities of untested chemicals. Regul. Toxicol. Pharmacol. (2007) (In Press).
Google Scholar
BAILEY AB, CHANDERBHAN R, COLLAZO-BRAIER N, CHEESEMAN MA, TWAROSKI ML: The use of structure–activity relationship analysis in the food contact notification program. Regul. Toxicol. Pharmacol. (2005)42:225-235.
PubMed Web of Science ®Google Scholar
KRUHLAK NL, BENZ RD, MATTHEWS EJ, CONTRERA JF: Progress in QSAR toxicity screening of impurities in pharmaceuticals and other FDA regulated products. Adv. Drug Deliv. Rev. (2007) (In Press).
PubMedGoogle Scholar
GREENE N: Computer systems for the prediction of toxicity: an update. Adv. Drug Deliv. Rev. (2002)54:417-431.
PubMed Web of Science ®Google Scholar
SNYDER DR, PEARL GS, MANDAKAS G, CHOY WN, GOODSAID F, ROSENBLUM IY: Assessment of the sensitivity of the computational programs DEREK, TOPKAT and MCASE in the prediction of the genotoxicity of pharmaceutical molecules. Environ. Mol. Mutagen. (2004)43:143-158.
PubMed Web of Science ®Google Scholar

Websites

http://webcasts.prous.com/fda2006/search2.asp?char=L&tab=6#;return%20false;2006 FDA Science Forum webcasts: a century of FDA science (2006).
Google Scholar
http://www.fda.gov/cder/Offices/OPS_IO/default.htmUS FDA/CDER Informatics and Computational Safety Analysis Staff (2006).
Google Scholar
http://www.leadscope.com/fdadb_cat.phpFDA toxicity databases made available through Leadscope, Inc. (2006).
Google Scholar
http://www.fda.gov/cder/dsm/DRG/drg00401.htmUS FDA/CDER ingredients dictionary (2006).
Google Scholar
http://www.usp.org/products/dictionary/US Pharmacopeia dictionary (2006).
Google Scholar
http://www.pjbpubs.com/pharmaprojects/index.htmPharmaprojects (2006).
Google Scholar
http://scientific.thomson.com/products/wdi/Derwent World Drug Index – Thomson Scientific (2006).
Google Scholar
http://www.thomson.com/content/healthcare/brand_overviews/MEDEC_DIR_PDR(2007).
Google Scholar
http://www.mdli.com/products/knowledge/pharmapendium/index.jspElsevier MDL PharmaPendium™ (2006).
Google Scholar
http://chem.sis.nlm.nih.gov/chemidplus/National Library of Medicine CHEMID+ (2006).
Google Scholar
http://www.fda.gov/Cder/foi/nda/index.htmUS FDA/CDER drug approval packages (2006).
Google Scholar
http://vm.cfsan.fda.gov/∼ dms/eafus.htmlUS FDA/CFSAN list of everything added to food (2006).
Google Scholar
http://ntp.niehs.nih.gov/index.cfm?objectid=084801F0-F43F-7B74-0BE549908B5E5C1CNational Toxicology Program long-term study reports and abstracts (2006).
Google Scholar
http://monographs.iarc.fr/IARC monographs on the evaluation of carcinogenic risks to humans (2006).
Google Scholar
http://potency.berkeley.edu/Carcinogenic potency project (2006).
Google Scholar
http://cfpub.epa.gov/oppref/rereg/status.cfm?show=reregEPA pesticide re-registration fact sheets (2006).
Google Scholar
http://depts.washington.edu/terisweb/Clinical teratology website (2006).
Google Scholar
http://www.mdl.com/products/predictive/rtecs/index.jspElsevier MDL registry of the toxic effects of chemical substance (2006).
Google Scholar
http://www.accessdata.fda.gov/scripts/cder/drugsatfda/index.cfmDrugs@FDA: information on US/FDA CDER approved drugs (2006).
Google Scholar
http://www.who.int/whopes/recommendations/en/World Health Organization safety and effectiveness publications (2006).
Google Scholar
http://www.ntis.gov/search/product.asp?ABBR=PB99500043&starDB=GRAHISTNational Technical Information Service (2006).
Google Scholar
http://www.fda.gov/cder/aers/default.htmUS FDA/CDER Adverse Event Reporting System (2006).
Google Scholar
http://www.ntis.gov/search/product.asp?ABBR=PB95505426&starDB=GRAHISTNational Technical Information Service (2006).
Google Scholar
http://www.epa.gov/oppt/newchems/tools/21ecosar.htmEPA New Chemicals Program ecological structure–activity relationships (2006).
Google Scholar
http://www.mst.dk/kemi/02040100.htmDanish EPA (Q)SAR-modeller (2006).
Google Scholar
http://www.fda.gov/cder/Offices/OPS_IO/ICSAS.htmInformatics and Computational Safety Analysis Staff (ICSAS) Programs and Activities (2006).
Google Scholar
http://ecb.jrc.it/REACH/European Chemicals Board – REACH (Registration, Evaluation and Authorisation of Chemicals) (2006).
Google Scholar
http://europa.eu.int/eur-lex/pri/en/oj/dat/2003/l_066/l_06620030311en00260035.pdfDirective 2003/15/EC of the European Parliament and of the Council of 27 February 2003 amending Council Directive 76/768/EEC on the approximation of the laws of the Member States relating to cosmetic products (2006).
Google Scholar
http://www.netsci.org/Science/Compchem/feature19.htmlIntroduction to QSAR methodology (2006).
Google Scholar
http://www.multicase.com/products/prod01.htmMultiCASE, Inc. MCASE/MC4PC (2006).
Google Scholar
http://www.mdl.com/products/predictive/qsar/index.jspElsevier MDL MDL® QSAR (2006).
Google Scholar
http://www.prous.com/default.aspProus Science (2006).
Google Scholar
http://www.leadscope.com/all_products.phpLeadscope, Inc. chemoinformatics platform for drug discovery (2006).
Google Scholar
http://www.bioreason.com/applications.phpBioreason, Inc. ClassPharmer (2006).
Google Scholar
http://www.lhasalimited.org/index.php?cat=2&sub_cat=64Lhasa, Ltd Derek for Windows (2006).
Google Scholar
http://www.epa.gov/oppt/cahp/pubs/can.htmEPA cancer expert system OncoLogic (2006).
Google Scholar
http://www-935.ibm.com/services/au/index.wss/ibvstudy/igs/a1007021?cntxt=a1005028additional_resourcesPharma 2005 – An industrial revolution in R&D (2006).
Google Scholar
http://vm.cfsan.fda.gov/∼frf/forum01/abst01sp.html2001 Science Forum Speakers’ Abstracts (2006).
Google Scholar
http://www.fda.gov/oc/initiatives/criticalpath/whitepaper.htmlUS FDA White Paper: innovation or stagnation: challenge and opportunity on the critical path to new medical products (2006).
Google Scholar

Reprints and Corporate Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

To request a reprint or corporate permissions for this article, please click on the relevant link below:

Order Reprints Request Corporate Permissions

Academic Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

Obtain permissions instantly via Rightslink by clicking on the button below:

Request Academic Permissions

If you are unable to obtain permissions via Rightslink, please complete and submit this Permissions form. For more information, please visit our Permissions help page.

Related research

People also read lists articles that other readers of this article have read.

Recommended articles lists articles that we recommend and is powered by our AI driven recommendation engine.

Cited by lists all citing articles based on Crossref citations.
Articles with the Crossref icon will open in a new tab.

People also read
Recommended articles
Cited by

To cite this article:

Reference style: APA Chicago Harvard

Citation copied to clipboard

Reference styles above use APA (6th edition), Chicago (16th edition) & Harvard (10th edition)

Download citation

Download a citation file in RIS format that can be imported by citation management software including EndNote, ProCite, RefWorks and Reference Manager.

Choose format: RIS BibTex RefWorks Direct Export

Choose options: Citation Citation & abstract Citation & references

Toxicological and clinical computational analysis and the US FDA/CDER

Bibliography

Websites

Information for

Open access

Opportunities

Help and information

Your download is now in progress and you may close this window

Login or register to access this feature

Toxicological and clinical computational analysis and the US FDA/CDER

Bibliography

Websites

Reprints and Corporate Permissions

Academic Permissions

Related research

To cite this article:

Download citation

Information for

Open access

Opportunities

Help and information

Keep up to date